Table 1.

Patient characteristics according to gender neoadjuvant chemotherapy (NAC) (n = 54).

	Overall	Male	Female	p
n (%)	54 (100)	42 (77.8)	12 (22.2)
Age (median [Interquartile range IQR])	64.00 [59.00, 69.00]	63.50 [59.00, 69.75]	66.00 [60.25, 69.00]	0.835
BMI (median [IQR])	26.49 [24.40, 29.72]	26.93 [24.85, 29.72]	24.59 [23.45, 26.95]	0.100
Concomitant CIS, n (%)	3 (5.7)	3 (7.3)	0 (0.0)	0.799
cT4, n (%)	4 (7.4)	3 (5.55)	1 (1.85)	1
ASA-score 3, n (%)	22 (40.7)	18 (42.9)	4 (33.3)	0.796
ESR1 Expression (median [IQR])	34.44 [33.24, 35.04]	34.58 [33.24, 35.04]	33.91 [33.28, 34.97]	0.546
ERBB2 Expression (median [IQR])	38.69 [38.05, 39.63]	38.67 [38.21, 39.61]	38.84 [37.72, 39.61]	0.851